Informações:
Falhas:
ID
42266
Descrição
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin); ODM derived from: https://clinicaltrials.gov/show/NCT00890006
Link
https://clinicaltrials.gov/show/NCT00890006
Palavras-chave
Versões (3)
- 13/05/2017 13/05/2017 -
- 10/04/2021 10/04/2021 - Ahmed Rafee, MD
- 26/04/2021 26/04/2021 - Sarah Riepenhausen
Titular dos direitos
MDM
Transferido a
26 de abril de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
- StudyEvent: Eligibility
Similar models
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
localized prostate cancer
Item
low or intermediate risk localized prostate cancer:
boolean
C0600139 (UMLS CUI [1])
gleason score
Item
gleason score ≤ 7
boolean
C0332326 (UMLS CUI [1])
psa
Item
psa <20
boolean
C0138741 (UMLS CUI [1])
prostate cancer stage
Item
stage t2a or less (stage 2 only)
boolean
C0280280 (UMLS CUI [1])
prostate cancer biopsy histology
Item
<50% of biopsy cores involved with tumor (stage 2 only)
boolean
C0600139 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0005558 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
hip replacement
Item
history of hip replacement
boolean
C0392806 (UMLS CUI [1])
inflammatory bowel disease, collagen vascular disease
Item
inflammatory bowel disease or collagen vascular disease
boolean
C0021390 (UMLS CUI [1])
C0262428 (UMLS CUI [2])
C0262428 (UMLS CUI [2])
fiducial markers contraindication
Item
contraindication to fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,2])
bleeding diathesis, anticoagulant therapy
Item
bleeding diathesis or anticoagulant therapy that cannot safely be ceased temporarily
boolean
C0005779 (UMLS CUI [1])
C0150457 (UMLS CUI [2])
C0150457 (UMLS CUI [2])
trus- guided prostate biopsy adverse event
Item
severe adverse event with prior trus-guided prostate biopsy
boolean
C0194804 (UMLS CUI [1,1])
C0373345 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0373345 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
patient refuses fiducial markers
Item
patient refuses fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C3242233 (UMLS CUI [1,2])
C3242233 (UMLS CUI [1,2])
mri contraindication
Item
contraindication to mri
boolean
C0024485 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C0522473 (UMLS CUI [1,2])
patient randomization
Item
patient randomization in profit trial (stage 2 only)
boolean
C0030705 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])
prostate radiotherapy
Item
patients not prescribed 78gy in 39 fractions to the prostate gland.
boolean
C0948317 (UMLS CUI [1])